IL-30 (IL-27A): a familiar stranger in immunity, inflammation, and cancer

Booki Min*, Dongkyun Kim, Matthias J. Feige

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Over the years, interleukin (IL)-27 has received much attention because of its highly divergent, sometimes even opposing, functions in immunity. IL-30, the p28 subunit that forms IL-27 together with Ebi3 and is also known as IL-27p28 or IL-27A, has been considered a surrogate to represent IL-27. However, it was later discovered that IL-30 can form complexes with other protein subunits, potentially leading to overlapping or discrete functions. Furthermore, there is emerging evidence that IL-30 itself may perform immunomodulatory functions independent of Ebi3 or other binding partners and that IL-30 production is strongly associated with certain cancers in humans. In this review, we will discuss the biology of IL-30 and other IL-30-associated cytokines and their functions in inflammation and cancer.

Original languageEnglish (US)
Pages (from-to)823-834
Number of pages12
JournalExperimental and Molecular Medicine
Issue number5
StatePublished - May 2021

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Biochemistry
  • Clinical Biochemistry


Dive into the research topics of 'IL-30 (IL-27A): a familiar stranger in immunity, inflammation, and cancer'. Together they form a unique fingerprint.

Cite this